Man Group
AMRX icon

Man Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Man Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,358
Closed -$352K – 2326
2026
Q1 		$352K Sell
28,358
-34,468
-55% -$463K ﹤0.01% 2176
2025
Q4 		$792K Sell
62,826
-274,455
-81% -$3.14M ﹤0.01% 1751
2025
Q3 		$3.38M Sell
337,281
-21,535
-6% -$193K 0.01% 1230
2025
Q2 		$2.9M Buy
358,816
+244,021
+213% +$1.84M 0.01% 1274
2025
Q1 		$962K Sell
114,795
-6,997
-6% -$58.4K ﹤0.01% 1593
2024
Q4 		$965K Buy
121,792
+94,263
+342% +$791K ﹤0.01% 1494
2024
Q3 		$229K Buy
+27,529
New +$215K ﹤0.01% 1829
2023
Q1 		– Sell
-55,151
Closed -$110K – 1863
2022
Q4 		$110K Buy
55,151
+29,448
+115% +$66K ﹤0.01% 1895
2022
Q3 		$52K Buy
+25,703
New +$72K ﹤0.01% 1891
2022
Q2 		– Sell
-21,925
Closed -$91K – 2039
2022
Q1 		$91K Buy
21,925
+9,053
+70% +$40.1K ﹤0.01% 2067
2021
Q4 		$62K Buy
12,872
+939
+8% +$4.68K ﹤0.01% 1900
2021
Q3 		$64K Sell
11,933
-1,225
-9% -$6.17K ﹤0.01% 1831
2021
Q2 		$67K Buy
+13,158
New +$74.8K ﹤0.01% 1876
2019
Q1 		– Sell
-91,400
Closed -$1.24M – 1945
2018
Q4 		$1.24M Buy
+91,400
New +$1.65M 0.01% 1387

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Man Group's AMRX Position: Q2 2026 in Review

Man Group sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 28,358 shares — an estimated $352K sold.

Man Group first reported a position in AMRX in Q4 2018 and held it in 14 quarters. The position peaked at $3.38M in Q3 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Man Group reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 28,358 Amneal Pharmaceuticals shares in Q2 2026, an estimated $352K.
  • Man Group first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 14 quarters.
  • Man Group's Amneal Pharmaceuticals position peaked at $3.38M in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.